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Background. Sexually transmitted infections (STIs) caused by the Gram-negative bacteria Chlamydia trachomatis and Neisseria gonorrhoeae 
are associated with an increased risk of HIV acquisition in South African women. HIV infection involves binding of the virus to CD4+ 
receptors on host cells and subsequent binding to a chemokine co-receptor that mediates fusion with the host target cell membrane.
Objective. To investigate the potential impact of STIs on HIV receptor expression in cervical epithelial cells, and the molecular pathways 
mediating this effect.
Methods. Expression of Toll-like receptor 4 (TLR4), CD4+ and CCR5 was investigated in HPV type 18-positive (HeLa) and HPV-negative 
(C33A) cervical epithelial cells, uterine adenocarcinoma cells (Ishikawa), cervical squamous cell carcinoma tissue and normal cervical tissue 
by real-time polymerase chain reaction (RT-PCR) analysis. HIV receptor expression in HeLa cells was investigated in the presence/absence 
of 10 µg/mL bacterial lipopolysaccharide (LPS) and chemical inhibitors of epidermal growth factor receptor (EGFR), extracellular signal-
regulated kinase (ERK1/2) or cyclo-oxygenase-2 (COX-2) by RT-PCR analysis.
Results. TLR4, CD4+ and CCR5 expression was elevated in HeLa, C33A and Ishikawa cell lines and carcinoma tissue, compared with 
normal cervical tissue. Treatment of HeLa cells with LPS increased expression of the primary HIV chemokine co-receptor CCR5 (p<0.01) 
and several alternative HIV receptors including CCR2b (p<0.01), CXCR6 (p<0.05) and GPR1 (p<0.05), but not CD4+. We found that LPS-
mediated CCR5 expression occurred via induction of the EGFR, ERK1/2 and COX-2 signalling pathways.
Conclusion. Our findings suggest that STIs have the potential to enhance susceptibility to HIV infection in women by regulating expression 
of HIV receptors in cervical epithelial cells.
S Afr Med J 2015;105(1):56-61. DOI:10.7196/SAMJ.8185
Sexually transmitted infections (STIs) with the Gram-
negative bacteria Chlamydia trachomatis and Neisseria 
gonorrhoeae are major public health problems in South 
Africa (SA) and are significantly associated with HIV 
infection.[1] In women, STI ultimately occurs at the 
mucosal surface of the genital tract, where inflammation from both 
non-ulcerative and ulcerative infections increases localised immune 
cell mobilisation, in turn enhancing susceptibility to HIV infection.[1] 
Although HIV preferentially targets CD4+-positive immune cells for 
infection, recent laboratory studies have shown that cervical epithelial 
cells can become productively infected and behave as viral reservoirs, 
sequestering and transferring virus to activated peripheral blood 
mononuclear cells in the submucosa.[2-5]
HIV infects cells via receptors on the host cell surface. The virus 
first attaches to the surface of the host cells. The initial step in 
membrane fusion begins with binding of the viral envelope protein 
(Env, consisting of a trimer of gp120-gp41 heterodimers) to the CD4+ 
cell surface protein and a chemokine co-receptor present on the host 
cell.[6] While most HIV-1 variants use CCR5 and CXCR4 as the main 
co-receptor in vivo, up to 12 other chemokine co-receptors (including 
CCR2b, CXCR6 and GPR1) for HIV infection have been identified 
in vitro.[7,8]
Although the molecular mechanisms regulating HIV chemokine 
receptors in the cervix are unclear, inflammatory prostaglandins 
derived by metabolism of arachidonic acid by cyclo-oxygenase 
enzymes (COX-1 and COX-2)[9] have been shown to regulate HIV 
chemokine expression in uterine epithelial cells in the female genital 
tract.[10] These observations suggest that inflammation can drive 
expression of HIV co-receptors in cervical epithelial cells.
We investigated: (i) the potential impact of Gram-negative bacterial 
STIs on the regulation of receptors involved in HIV infection in the 
cervix using the endotoxic component of the Gram-negative bacteria, 
lipopolysaccharide (LPS), as a mimetic of infection; and (ii) the 
potential molecular pathways underlying the action of LPS.
Methods
Reagents 
Phosphate-buffered saline (PBS) and Tri-reagent® were purchased 
from Sigma Chemical Company (SA). AG1478, SC560, NS398 and 
PD98059 were purchased from Calbiochem (Merck, Germany). 
CCR5 (CKR5; sc-6128) antibody was purchased from Santa Cruz 
Biotechnology (Whitehead Scientific, SA).
Ethics approval 
Ethics approval for the study was obtained from the University 
of Cape Town Research Ethics Committee (REC/REF: 067/2011). 
Written informed consent was obtained from all subjects before 
sample collection.
Tissue collection
Cervical cancer tissue specimens were obtained at the time of surgery 
or biopsy from patients who were attending the gynaecological 
oncology clinic at Groote Schuur Hospital (GSH), Cape Town, 
SA, and had previously been diagnosed with stage 1A moderately 
differentiated squamous cell carcinoma of the cervix (N=10). The 
median age of the patients was 41 years. Histologically normal 
cervical tissue (N=10) was collected from women undergoing 
Wertheim’s hysterectomy for benign gynaecological indications at 
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GSH. The median age of these patients was 50.5 years. Sections of 
tissue were excised from the ectocervix-transformational zone by 
a specialist pathologist. Tissue sections were placed into a 15 mL 
collection tube containing serum-free Dulbecco’s Modified Eagle 
Medium supplemented with 1% penicillin-streptomycin. The 
tubes were placed on ice and transported to the laboratory. Each 
sample was divided equally into aliquots before snap-freezing 
using liquid nitrogen. 
Cell culture and treatments
HeLa cells authenticated and verified as cervical adenocarcinoma 
cells containing HPV type 18 were purchased from Bio-Whittaker 
(UK). C33A cells were a gift from Prof. Virna Leaner (Division 
of Medical Biochemistry, University of Cape Town). Ishikawa 
cells were obtained from the European Collection of Cell Culture 
(UK). All cell lines were cultured as described previously.[10] For 
HeLa cell experiments, cells were seeded at a density of 2 × 105 
cells in 3 cm dishes and allowed to attach and grow overnight. The 
following day, cells were serum starved for 24 hours in serum-free 
medium. Cells were then treated with vehicle (PBS) or 10 µg/mL 
LPS for 4, 8, 16 or 24 hours. For inhibitor experiments, cells were 
serum starved and treated with inhibitor alone or 10 µg/mL LPS 
and inhibitor of epidermal growth factor receptor (EGFR) tyrosine 
kinase (AG1478; 200 nM), extracellular signal-regulated kinase 
(ERK1/2) (PD98059; 50 µM), COX-1 (SC-560; 10 µM) or COX-2 
(NS398; 10 µM). The concentrations of chemical inhibitors were 
determined empirically by titration using the IC50 values from the 
manufacturer as a guide. At the concentrations and time used, the 
inhibitors showed no adverse effect on cell viability. Fold increase 
was calculated by dividing the values obtained from the LPS only/
LPS plus inhibitor treatments by the vehicle only/vehicle plus 
inhibitor treatments.
Real-time polymerase chain reaction (RT-PCR) analysis
RNA was extracted using Tri-reagent (Sigma) following the 
manufacturer’s guidelines and reverse transcribed as described 
previously.[10] All gene expression experiments were carried out on 
an Illumina Eco™ quantitative RT-PCR machine and detected using 
SYBR green (Bioline, Celtic Molecular, SA) incorporation during 
the PCR reaction. Sequences of PCR primers used are outlined in 
Table 1. A melt curve was performed for each PCR reaction, and 
all PCR products gave a single peak confirming the purity of the 
PCR product. Results were calculated using the comparative cycle 
threshold (Ct) method, and expression of each cDNA sample was 
normalised for RNA loading using the average Ct value obtained 
from two independent reference genes (18s ribosomal RNA and 
glyceraldehyde 3-phosphate dehydrogenase) as internal controls. All 
data were expressed relative to an endogenous control of HeLa cell 
cDNA included in each experiment or converted to fold increase, 
which was determined by dividing the relative expression of the 
treatment group by the relative expression of each control group. The 
experiment was conducted in duplicate and data were presented as 
means (standard error of the mean (SEM)).
Western blot analysis
Cell lysis, protein quantification and immunoblot experiments were 
conducted as described previously,[11] using a specific CCR5 antibody. 
CCR5 protein was revealed by chemiluminescence and quantified 
using a UVP BioSpectrum 500 Imaging System (Scientific Group, 
SA). The experiment was conducted three times and data were 
presented as means (SEM).
Statistical analysis
Statistical analysis was performed using one-way analysis of 
variance and the Newman-Keuls multiple comparison or Dunnett 
post-hoc test to compare differences in gene expression between 
the experimental groups. A paired t-test was conducted between 
vehicle and LPS-treated cells on the untransformed means, before 
conversion to fold increase. An unpaired t-test was used to compare 
CCR5 expression in samples treated with LPS in the presence of 
signalling inhibitors with that in samples treated with LPS only. 
Analysis and histograms were generated using Graphpad Prism 
software version 5.00 (Graph Pad, USA). Data were considered 
significant at p<0.05.
Results
Expression of TLR4, CD4+ and CCR5 in  
uterine-cervical cells and tissues
We hypothesised that the endotoxic LPS component of the Gram-
negative bacteria C. trachomatis and N. gonorrhoeae, often transmitted 
during sexual intercourse and deposited in the vagina and cervix, 
could impact on HIV receptor expression in the cervical mucosa. LPS 
mediates its effect via a signalling receptor, Toll-like receptor 4 (TLR4), 
to alter signal transduction pathways and increase inflammatory gene 
expression. We initially investigated the expression of TLR4 in HPV 
type 18-transformed cervical cancer cells (HeLa), HPV-negative 
cervical cancer cells (C33A), uterine endometrial adenocarcinoma 
cells (Ishikawa), cervical squamous cell carcinoma tissue and normal 
cervical tissue by quantitative RT-PCR analysis.
We found differential expression of TLR4 (Fig. 1, A), CCR5 (Fig. 1, 
B) and CD4+ (Fig. 1, C) in all cell lines and tissues investigated. 
TLR4 expression was higher in HeLa cells, Ishikawa cells and cancer 
tissues than in C33A cells or normal cervical tissue (Fig. 1, A; 
*p<0.05, **p<0.01). CCR5 (Fig. 1, B; p<0.05) and CD4+ (Fig. 1, C; 
p<0.05) expression was elevated in cervical cancer tissue compared 
with normal cervical tissue, but was not significantly different from 
expression in HeLa cells, C33A cells or Ishikawa cells.
LPS regulates expression of HIV receptors in HeLa cells
Since we had determined that TLR4 was present in cervical tissues and 
could therefore mediate inflammatory signalling in the cervical mucosa, 
Table 1. Primer sequences for RT-PCR
Gene target Primer sequence
CD4+ FOR CTAAGCTCCAGATGGGCAAG
CD4+ REV CACCACCAGGTTCACTTCCT
CCR5 FOR AGCTATGCAGGTGACAGAGACTCTT
CCR5 REV TCCCCGACAAAGGCATAGAT
CCR2b FOR TGCCTGACTCACACTCAAGG
CCR2b REV GGCTTCTCAGCAACTGAACC
CXCR4 FOR CAGTGGCCGACCTCCTCTT
CXCR4 REV CAGTTTGCCACGGCATCA
CXCR6 FOR GGTTCTTCTTGCCACTGCTC
CXCR6 REV CATGAGGTTGAAGGGCATCT
GPR1 FOR TTCTGCCCCTGTACATCTCC
GPR1 REV AGAAGCCAAAAGCCAGATGA
TLR4 FOR AGAGTTTCCTGCAATGGATCAAG
TLR4 REV TGCTTATCTGAA GGTGTTGCACAT
RT-PCR = real-time polymerase chain reaction.
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we next investigated the impact of LPS stimulation on HIV receptor 
expression in cervical epithelial cells, using HeLa cells as a model system. 
HeLa cells were treated with vehicle (dark bars in Fig. 2) or LPS (light 
bars) for 4, 8, 16 and 24 hours, and the RNA was extracted and subjected 
to reverse transcription and quantitative RT-PCR analysis. We found 
that CCR5 expression increased in a time-dependent manner, reaching 
a maximum at 24 hours (Fig. 2, A; p<0.01). We found no significant 
alteration in expression levels of the main HIV receptor CD4+ in response 
to LPS treatment at any time point investigated (Fig. 2, B).
HIV-1 and HIV-2 strains have been reported to be capable of 
utilising several alternative chemokine receptors, including CCR2b, 
CXCR4, CXCR6 and GPR1, to mediate infection of cells.[7,8] We found 
that LPS stimulation of HeLa cells increased CCR2b (Fig. 2, C; p<0.01), 
CXCR6 (Fig. 2, E; p<0.05) and GPR1 (Fig. 2, F; p<0.05) at 4, 8 and 24 
hours, respectively, compared with vehicle-treated cells. In contrast, 
we found no difference in CXCR4 receptor expression in HeLa cells 
treated with LPS at any time point investigated (Fig. 2, D). These data 
indicate that LPS could potentially regulate expression of a host of 
chemokine co-receptors in the cervix, which could mediate infection 
of cells by HIV strains capable of utilising alternative CD4+-co-receptor 
combinations, different from CD4+-CCR5 or CD4+-CXCR4.
LPS induces CCR5 receptor expression via the  
EGFR, COX-2 and ERK1/2 pathways
Since CCR5 is the main receptor utilised by HIV strains for infection, 
we focused our analysis on this molecule. We have previously 
Fig. 1. Relative expression of TLR4 (A), CCR5 (B) and CD4+ (C) in uterine-cervical cells and tissues (HeLa cells (n=3), C33A cells (n=3), Ishikawa cells 
(n=3), cervical squamous cell carcinoma tissue (n=10) and normal cervical tissue (n=10)), as determined by quantitative RT-PCR analysis. * and ** represent 
significance at p<0.05 and p<0.01, respectively, as determined by analysis of variance with Dunnett’s post-test analysis. Data are presented as means (SEM). 
(TLR4 = Toll-like receptor 4; RT-PCR = real-time polymerase chain reaction; SEM = standard error of the mean.)
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highlighted a role for the inflammatory COX-prostaglandin 
pathway in mediating chemokine receptor expression in the female 
reproductive tract via the EGFR and ERK1/2 pathways.[10] In the 
present study, we investigated the role of the EGFR, ERK1/2 and COX 
pathways in regulating CCR5 expression, using a panel of specific 
chemical inhibitors of cellular signalling. HeLa cells were treated 
with vehicle or LPS in the presence/absence of inhibitors of EGFR 
kinase (AG1478), ERK1/2 (PD98059), COX-1 (SC560) or COX-2 
(NS398) for 24 hours, and the mRNA and protein were subjected to 
quantitative RT-PCR (Fig. 3, A) and Western blot (Fig. 3, B) analysis, 
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Fig. 2. LPS induces expression of HIV chemokine co-receptors in HeLa cells. (A) CCR5, (B) CD4+, (C) CCR2b, (D) CXCR4, (E) CXCR6 and (F) GPR1 mRNA 
expression as determined by RT-PCR analysis. HeLa cells were treated with control (PBS, dark bars) or 10 µg/mL LPS (light bars) for 4, 8, 16 or 24 hours. 
Data are presented as means (SEM) from six individual experiments done in duplicate. * and ** indicate significance at p<0.05 and p<0.01, respectively, for 
treatment v. control as determined by the paired t-test and analysis of variance. (LPS = lipopolysaccharide; RT-PCR = real-time polymerase chain reaction; 
PBS = phosphate-buffered saline; SEM = standard error of the mean.)
RESEARCH
60      January 2015, Vol. 105, No. 1
respectively. We found that AG1478, PD98059 and NS398, but not 
SC560, significantly inhibited the LPS-mediated induction of CCR5 
mRNA (Fig. 3, A) and protein (Fig. 3, B) in HeLa cells (*p<0.05, 
**p<0.01).
Discussion
Inflammation of the cervical mucosa is considered a significant 
risk factor for HIV infection.[1] However, the roles of inflammatory 
mediators and STIs in regulating pathways involved in HIV infection 
in the cervix have yet to be fully elucidated. The endotoxic component 
of Gram-negative bacteria, LPS, is found on the outer bacterial 
membrane and is responsible for eliciting strong immune responses, 
associated with infection, by binding to and activating TLR4.[12] 
We hypothesised that this endotoxic component of Gram-negative 
bacteria, which is abundantly part of the make-up of C. trachomatis 
and N. gonorrhoeae, could regulate chemokine receptors and pathways 
with known roles in HIV infection in cervical epithelial cells to 
enhance susceptibility of the genital tract to infection.
To investigate whether the endotoxic component of Gram-negative 
bacteria, LPS, could have an impact on cervical epithelial cells, 
we screened several uterine-cervical epithelial cell lines, cervical 
squamous cell carcinomas and normal cervical cells to determine 
whether TLR4 was present. We found that all cell lines and tissues 
expressed TLR4, the signalling receptor for LPS, as well as the main 
HIV receptors CD4+ and CCR5. These findings indicated that all 
cell lines and tissues expressed the necessary cellular machinery to 
mediate infection of the cervix by Gram-negative bacteria and HIV.
The epithelial compartment of several tissues in the human 
body, including the gastrointestinal tract, prostate and cervix, has 
been implicated in the uptake and transport of HIV to submucosal 
leucocytes.[5,13] Of significance to our study is the observation that 
cervical epithelial cells can behave as viral reservoirs, to sequester and 
transfer virus to activated peripheral blood mononuclear cells in the 
submucosa.[2,5,14] Moreover, several studies have shown that levels of 
CCR5 in cells positively correlate with HIV infectivity and levels of 
cellular activation in vivo.[4,15,16]
It is therefore plausible that any mechanism that enhances 
CCR5 expression, or indeed expression of other alternative HIV 
co-receptors such as CCR2b, CXCR6 and GPR1 investigated in this 
study, could enhance HIV susceptibility. In sexually active women, 
this could be enhanced by bacterial STIs mediated by C. trachomatis 
and N.  gonorrhoeae. These agents of infection could mediate HIV 
infection both directly by regulating cell surface expression of 
chemokine G protein-coupled receptors to mediate virus fusion 
and infection and indirectly by facilitating the recruitment of CD4+- 
positive immune cells into the local cervical environment, which 
could then be targeted by HIV for infection.
Exploring the intracellular pathways mediating the induction of 
CCR5 by LPS, we found that LPS regulates CCR5 mRNA and protein 
expression in HeLa cells via the EGFR, ERK1/2 and inflammatory 
COX-2 pathways. Many pathological disorders or diseases, including 
cervical cancer, have been characterised by the exacerbated activation 
and maintenance of these inflammatory pathways.[17] Over the past 
two decades, significant attention has been paid to inhibition of 
the inflammatory COX enzyme pathway as a potential therapeutic 
intervention strategy for a host of inflammatory diseases. Our 
observations of the role of COX-2 in regulating CCR5 expression 
suggest that administration of non-steroidal anti-inflammatory 
drugs such as aspirin to suppress COX-2 expression in sexually 
active women with lower urinary tract bacterial infections might 
also suppress inflammatory pathways that regulate HIV receptor 
expression and susceptibility to HIV infection.
Our study shows that the endotoxic LPS component of bacterial 
STIs, which are very common in sexually active women, often in 
the absence of any symptoms of infection, can regulate expression 
of HIV receptors in the cervical epithelium. Since levels of HIV 
receptor positively correlate with HIV infectivity, and since the 
cervical mucosa is known to become productively infected by virus, 
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Fig. 3. Effects of chemical inhibitors of specific signal transduction pathways on CCR5 expression. Chemical inhibitors used: EGFR kinase (AG1478), ERK1/2 
(PD98059), COX-1 (SC560) and COX-2 (NS398). HeLa cells were treated with vehicle or inhibitor in the presence/absence of 10 µg/mL LPS for 24 hours. (A) 
CCR5 mRNA expression was analysed and quantified using quantitative RT-PCR analysis. (B) LPS regulation of CCR5 protein expression was confirmed by 
Western blot analysis using a specific CCR5 antibody. Data are represented as means (SEM) of three independent experiments. * and ** represent significance 
at p<0.05 and p<0.01, respectively, as determined by the unpaired t-test. (EGFR = epidermal growth factor receptor; LPS = lipopolysaccharide; ERK1/2 = 
extracellular signal-regulated kinase; RT-PCR = real-time polymerase chain reaction; SEM = standard error of the mean; NS = not significant.)
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our data highlight the potential of STIs for enhancing the risk of 
infection by HIV during intercourse, by increasing the abundance 
of cell surface machinery used by the HI virus for establishment of 
infection.
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